Product Information

IMVEXXY 4 MCG MAINTENANCE PACK is a brand product labeled by Mayne Pharma, priced at $26.9931 per EA under NDC 68308074708. Its NADAC has been published 122 times since Jul 17, 2024.

FDA first approved this application on May 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

IMVEXXY 4 MCG MAINTENANCE PACK

estradiol
$26.9931per EA
High Outlier

Strength

4 ug/1

Manufacturer

Mayne Pharma

NDC

68308074708

Classification

Brand

Dosage Form

INSERT

Route

VAGINAL

Effective Date

10/21/2026

Active Ingredients

ESTRADIOL

Approval Type

New Drug (NDA)

FDA Application

NDA208564

FDA Approved

5/29/2018

TE Code

AB

On Market Since

5/3/2024

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen

Price Statistics

The NADAC for IMVEXXY 4 MCG MAINTENANCE PACK has been published 122 times since Jul 17, 2024, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.

Current price$26.9931 per EA
All-time high$27.0962 (Oct 14, 2026)
All-time low$25.7845 (Feb 18, 2026)
52-week high$27.0962
52-week low$25.7845
Median price$25.8336
Average price$26.0704
Largest weekly change+5.0% (Jun 3, 2026)
Weeks tracked122
Tracking sinceJul 17, 2024

Price History

1W

0.0%

1M

-0.4%

3M

-0.4%

6M

+4.6%

1Y

+4.6%

3Y

N/A

5Y

N/A

All

+4.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMVEXXY 4 MCG MAINTENANCE PACK?

The current National Average Drug Acquisition Cost (NADAC) for IMVEXXY 4 MCG MAINTENANCE PACK, manufactured by Mayne Pharma, is $26.9931 per EA (NDC 68308074708), effective Nov 11, 2026.

How has the price of IMVEXXY 4 MCG MAINTENANCE PACK changed over time?

Over the history we have for it, the NADAC for IMVEXXY 4 MCG MAINTENANCE PACK has risen 4.6%. It has been tracked across 122 weekly CMS publications since Jul 17, 2024.

What are the highest and lowest recorded NADAC prices for IMVEXXY 4 MCG MAINTENANCE PACK?

Since Jul 17, 2024, the NADAC for IMVEXXY 4 MCG MAINTENANCE PACK has ranged from a low of $25.7845 (Feb 18, 2026) to a high of $27.0962 (Oct 14, 2026), with a median of $25.8336 per EA.

Are there cheaper alternatives to IMVEXXY 4 MCG MAINTENANCE PACK?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IMVEXXY 4 MCG STARTER PACK, is $26.9671 per EA — about 0% below IMVEXXY 4 MCG MAINTENANCE PACK.

Who manufactures IMVEXXY 4 MCG MAINTENANCE PACK?

IMVEXXY 4 MCG MAINTENANCE PACK (NDC 68308074708) is labeled by Mayne Pharma, and CMS classifies it as a brand product.